期刊文献+

苯唑西林和头孢西丁纸片扩散法现行耐药折点判断凝固酶阴性葡萄球菌甲氧西林耐药性的评价 被引量:1

Evaluation of the breakpoints of oxacillin and cefoxitin discs for judging methicillin resistance in coagulase-negative staphylococci
下载PDF
导出
摘要 目的评价苯唑西林和头孢西丁纸片扩散法现行耐药折点在判断凝固酶阴性葡萄球菌(CNS)甲氧西林耐药性中的准确性。方法苯唑西林(1μg)和头孢西丁(30μg)纸片扩散法测定149株临床分离的CNS对甲氧西林的耐药性,量取两种纸片的抑菌环直径。对苯唑西林组分别以≤14mm、≤15mm、≤16mm、≤17mm(CLSI/NCCLS2004标准)为耐药折点,对头孢西丁组分别以≤21mm、≤22mm、≤23mm、≤24mm(CLSI/NCCLS2004年标准)为耐药折点,与mecA基因检测结果比较,评价两种纸片扩散法在各折点对耐甲氧西林CNS判断的敏感性和特异性。结果与mecA基因检测结果比较,苯唑西林纸片扩散法在不同的耐药折点判断耐甲氧西林表皮葡萄球菌的敏感性分别为52.3%、75.0%、90.9%、100%,特异性都为100%,判断耐甲氧西林非表皮葡萄球菌CNS的敏感性分别为66.7%、79.0%、90.1%、97.5%,特异性分别为100%、100%、100%、94.4%;头孢西丁纸片扩散法在不同耐药折点判断耐甲氧西林表皮葡萄球菌的敏感性分别为45.5%、70.1%、90.9%、100%,特异性都为100%,判断耐甲氧西林非表皮葡萄球菌CNS的敏感性分别为83.6%、91.8%、97.3%、100%,特异性都为100%。结论苯唑西林和头孢西丁纸片扩散法检测耐甲氧西林CNS的现行耐药折点标准在判断表皮葡萄球菌和非表皮葡萄球菌CNS的甲氧西林耐药性中都有很高的敏感性和特异性,适用于CNS对甲氧西林耐药性的判断。对于非表皮葡萄球菌CNS,头孢西丁纸片扩散法较苯唑西林纸片扩散法结果更可靠。 Objective To evaluate the accuracy of the existing oxacillin and cefoxitin disc diffusion method for the resistant breakpoints judgement of methicillin resistance in coagulase-negative staphylococci (CNS). Methods One hundred and forty-nine strains of clinically isolated CNS were tested. The oxacillin (1μg), cefoxitin (30μg) disc diffusion methods and PCR amplification of the mecA gene were performed simultaneously. The diameters of the inhibition zone were measured. Taking ≤ 14mm, ≤ 15mm, ≤ 16mm and ≤ 17mm (CLSI/NCCLS 2004 standard) as the resistant breakpoints to oxacillin group; taking ≤ 21mm, ≤ 22mm, ≤ 23mm and ≤ 24mm (CLSI/NCCLS 2004 standard) as the resistant breakpoints to cefoxitin group, respectively. The sensitivity and specificity of the above two groups in the judgement of methicillin-resistant CNS were evaluated by comparing with the results of mecA PCR. Results Compared with the results of mecA gene amplification, the sensitivity of oxacillin disc diffusion against S. epidermidis at different breakpoints were 52.3%, 75.0%, 90.9% and 100%, respectively, and the specificity of all were 100% in the judgement of methicillin-resistant S. epidermidis, while the sensitivity of oxacillin against methicillin-resistant non- S. epidermidis CNS were 66. 7%, 79.0%, 90. 1%, 97.5% and 100%, 100%, 100%, 94.4%, respectively. Those of cefoxitin disc diffusion against S. epidermidis at different breakpoints were 45.5%, 70. 1%, 90. 9% 100% and 100% , respectively, while the sensitivity of cefoxitin against non-S. epidermidis CNS were 83.6%, 91.8%, 97.3%, 100%, respectively and the specificity of all break points was 100% in non-S, epidermidis CNS. Conclusions The exsiting resistant breakpoints standards of oxacillin and cefoxitin disc diffusion methods for the judgement of methicillin-resistant CNS are of higher sensitivity and specificity to methicillin-resistant S. epidermidis and non- S. epidermidis, and can be used to judge methicillin resistance of CNS. Nevertheless the results of cefoxitin disc is more reliable than oxacillin disc for non-S, epidermidis CNS.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2006年第7期425-428,共4页 Chinese Journal of Antibiotics
基金 浙江省教育厅科研基金项目资助(20051146) 温州医学院科研发展基金项目资助(2003X21)
关键词 苯唑西林 头孢西丁 纸片扩散法 甲氧西林耐药性 凝固酶阴性葡萄球菌 Oxacillin Cefoxitin Disc diffusion method Methicillin resistance Coagulase-negative staphylococci
  • 相关文献

参考文献8

  • 1马越,姚蕾,陈鸿波,李景云,张力,胡昌勤,金少鸿.中国51家医院2000年葡萄球菌属临床分离株的耐药性[J].中国抗感染化疗杂志,2002,2(1):24-26. 被引量:59
  • 2李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
  • 3李景云,马越,张力,胡昌勤,金少鸿.2002年血液标本分离的革兰氏阳性球菌的耐药性[J].中国抗生素杂志,2004,29(9):545-548. 被引量:3
  • 4Woodford N,Johnson A P,Morrison D,et al.Current perspectives on glycopeptide resistance[J].Clin Microbiol,1995,8:585
  • 5Chang S,Sievert D M,Hageman J C,et al.Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene[J].N Engl J Med,2003,348:1342
  • 6NCCLS.Performance standards for antimicrobial susceptibility testing,Fourteenth informational supplement.NCCLS document M100-S14[S].Wayne,Pennsylvania.National Committee for Clinical Laboratory Standards,2004,24(1):1
  • 7NCCLS.Performance standards for antimicrobial susceptibility testing,Thirteenth informational supplement.NCCLS document M100-S13[S].Wayne,Pennsylvania.National Committee for Clinical Laboratory Standards,2003,23 (1):1
  • 8Clinical and Laboratory Standards Institute/NCCLS.Performance standards for antimicrobial susceptibility testing,Fifteenth informational supplement.CLSI/NCCLS document M100-S15[S].Wayne,Pennsylvania,Clinical and Laboratory Standards Institute,2005,25 (1):1

二级参考文献33

  • 1National Committee for Clinical Laboratory Standard, 2002. Performance standards for antimicrobial susceptibility testing. Wayne.Pennsylvania:NCCLS, 2002.1- 50.
  • 2Jeijaszewicz J, Mlynarczyk G, Mlynarcqyk A. Antibiotic resistance in Gram-positive cocci. Int J Antimicrob Chemother, 2000,16:473-478.
  • 3Mutnick AH, Biedenbach DJ, Turnidge JD, et al. Spectrum and potency evaluation of a new oxazolidinone, linezolid:report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Diagn Microbiol Infect Dis, 2002,43:65-73.
  • 4Jones RN, Biedenbach DJ,Beach ML.Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001):report from the SENTRY Antimicrobial Surveillance Program. Diag Microbiol Infect Dis, 2003,46:77-80.
  • 5Biedenbach DJ, Stephen JM ,Jones RN. Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp.collected in the SENTRY Antimicrobial Surveillance Program-North America, 2001. Diag Microbiol Infect Dis, 2003,46:291-294.
  • 6Biedenbach DJ, Jones RN. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones:prevalence results from the SENTRY Antimicrobial Surveillance Program. Diag Microbiol Infect Dis, 2003,46:55-61.
  • 7Avanzini C, Bosio K, Volpe G, et al. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998:Survey of macrolide resistance and trend of genotype by RAPD. Microbial Drug Resistance, 2000,6:289-295.
  • 8Mutnick AH, Biedenbach DJ, Jones RN. Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997-2000). Diag Microbiol Infect Dis, 2003,46:63-68.
  • 9Barbara S R, Gail L W, Richard B T, et al. Specimen processing [A]. Murray P R, Baron E J, Praller M A, et al. Manual of Clinical Microbiology [M]. 7th edition,Washington, D. C: ASM Press, 1999: 65
  • 10National Committee for Clinical Laboratory Standards,2002. Performance standards for antimicrobial susceptibility testing. Approved Standard [S]. 12th edition. M100-S12. NCCLS, Wayne, pa Ps0-58966-70

共引文献280

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部